📰 Genentech News
Page 108 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
August 31, 2023
Second quarter revenue increased 19% year over year to $107.6 million Second quarter GAAP operating loss of $26.2 million, non-GAAP operating income of $14.3 million Named Leader in the 2023...
August 31, 2023
/PRNewswire/ -- The "Global mRNA Cancer Vaccines Market Opportunity & Clinical Pipeline Insight 2023" drug pipelines has been added to ResearchAndMarkets.coms...
August 30, 2023
It is already changing how pharma companies make drugs
August 30, 2023
The NHS will be the first in the world to offer an injection that treats cancer to hundreds of patients in England, which could cut treatment times...
August 30, 2023
Britain's state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three quarters. Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England
August 30, 2023
The injection could cut treatment times by up to three-quarters. Read more at straitstimes.com.
August 30, 2023
Clinical collaboration marks an important milestone in partnership with Exelixis to further develop cabozantinib Participation will provide Ipsen access...
August 30, 2023
Following the green light from the Medicines and Healthcare products Regulatory Agency (MHRA), the NHS in England will be the first health system in t
August 30, 2023
Negotiated prices are set to be announced by September 2024 to go into effect on Jan. 1, 2026
August 30, 2023
Clinical trial will also explore single-agent activity of cabozantinib in the first-line setting - ALAMEDA, Calif. & PARIS - December 5, 2018 -Exelixis, Inc. and Ipsen today...